Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Apr;26(4):580-90.
doi: 10.1089/thy.2015.0418. Epub 2016 Mar 3.

Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis

Spyridoula Maraka et al. Thyroid. 2016 Apr.

Abstract

Background: The impact of subclinical hypothyroidism (SCH) and of levothyroxine replacement in pregnant women with SCH is unclear. The aims of this study were to assess (i) the impact of SCH during pregnancy on maternal and neonatal outcomes, and (ii) the effect of levothyroxine replacement therapy in these patients.

Methods: Ovid MEDLINE In-Process & Other Non-Indexed Citations, Ovid MEDLINE, the Cochrane Controlled Trials Register, Ovid EMBASE, Web of Science, and Scopus were searched from inception to January 2015. Randomized trials and cohort studies of pregnant women with SCH that examined adverse pregnancy and neonatal outcomes were included. Reviewers extracted data and assessed methodological quality in duplicate. Eighteen cohort studies at low-to-moderate risk of bias were included. Compared with euthyroid pregnant women, pregnant women with SCH were at higher risk for pregnancy loss (relative risk [RR] 2.01 [confidence interval (CI) 1.66-2.44]), placental abruption (RR 2.14 [CI 1.23-3.70]), premature rupture of membranes (RR 1.43 [CI 1.04-1.95]), and neonatal death (RR 2.58 [CI 1.41-4.73]). One study at high risk of bias compared pregnant women with SCH who received levothyroxine to those who did not and found no significant decrease in the rate of pregnancy loss, preterm delivery, gestational hypertension, low birth weight, or low Apgar score.

Conclusions: SCH during pregnancy is associated with multiple adverse maternal and neonatal outcomes. The value of levothyroxine therapy in preventing these adverse outcomes remains uncertain.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
(A) Forest plot of relative risk and 95% confidence interval (CI) of pooled studies comparing pregnant women with subclinical hypothyroidism to euthyroid pregnant women for risk of pregnancy loss. (B) Forest plot of relative risk and 95% CI of pooled studies comparing pregnant women with subclinical hypothyroidism to euthyroid pregnant women for risk of pregnancy loss (i) gestational age at screening at 0–12 weeks (first trimester) and (ii) gestational age at screening including 13–20 weeks (early pregnancy).

References

    1. Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, Faix JD, Klein RZ. 2000. Maternal thyroid deficiency and pregnancy complications: Implications for population screening. J Med Screen 7:127–130 - PubMed
    1. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W. 2011. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21:1081–1125 - PMC - PubMed
    1. Blatt AJ, Nakamoto JM, Kaufman HW. 2012. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab 97:777–784 - PubMed
    1. Negro R, Stagnaro-Green A. 2014. Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ 349:g4929. - PubMed
    1. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, Cunningham FG. 2005. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105:239–245 - PubMed

Publication types

LinkOut - more resources